Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Amoxicillin 250mg Capsules - PA0126/282/001
- Amoxicilin 500mg Capsules - PA0126/282/002
- Amoxicilin 250mg/5ml Powder for Oral Solution - PA0126/282/004
- Distaclor Tablets 375mg - PA1226/001/004
- Epanutin 100mg Capsules - PA23055/003/003
- Epanutin 300mg Capsules - PA23055/003/004
- Medispray Oromucosal Spray - PA0126/300/001
- Norditropin FlexPro 10mg/1.5ml, Solution for Injection in Pre-Filled Pen - PA0218/040/012
- Olmesartan 20mg Film-Coated Tablets - PA0126/273/002
- Rocuronium 10mg/ml Solution for Injection/Infusion - PA0736/029/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Keflex 125 mg/5 ml Powder for Oral Suspension - PA1226/002/002
- Molipaxin 100mg Hard Capsules - PA540/056/002
- Mydrilate 0.5% Eye Drops - PA22709/003/001
- Mydrilate 1.0% Eye Drops - PA22709/003/002
- Octreotide 500mcg/1ml Solution for Injection - PA0822/218/004
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.